Connect with us


Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions



CAMBRIDGE, Mass., July 10, 2024 /PRNewswire/ — Flagship Pioneering, the bioplatform innovation company, today announced additions to its leadership team through key executive appointments and promotions. Today’s personnel announcement accompanies Flagship’s announced expansion of its capital base with a capital pool of $3.6 billion to support the origination and growth of an estimated 25 breakthrough platform companies in human health, sustainability, and AI.

Lovisa Afzelius, Ph.D., has been promoted to General Partner. Afzelius joined Flagship in 2020 after leading Pfizer’s systems immunology function, where she served as executive director of clinical programs. A computational scientist by training, Afzelius came to Flagship with twenty years of leadership experience. Afzelius’ past roles included CEO, co-founder, president, chairperson of the board, and executive director in both emerging biotech and large pharma companies.

“Lovisa has showcased her exemplary leadership, vision, and commitment to pioneering original science, as evidenced by her instrumental role in the creation and scaling-up of Alltrna, Apriori Bio, Metaphore Biotechnologies, and Prologue Medicines,” said Noubar Afeyan, Ph.D., Founder and CEO of Flagship Pioneering. “I am pleased with the promotion of Lovisa to General Partner, and look forward to her continued dedication to our mission.”

Paul Biondi has also been promoted to General Partner. Biondi joined Flagship in 2019 following nearly two decades at Bristol-Myers Squibb (BMS), where he most recently served as Senior Vice President of Strategy and Business Development. As President of Flagship’s Pioneering Medicines, Biondi has grown the initiative into a robust drug development unit with a leading team of experts who bring a broad set of capabilities to Flagship and its platforms. Under Biondi’s leadership, Pioneering Medicines has established strategic partnerships with the Cystic Fibrosis Foundation, Novo Nordisk, and Pfizer.

“In just four years since he joined Flagship, Paul has transformed then nascent Pioneering Medicines into an innovation powerhouse, where thanks to his vision and leadership, we boast an R&D unit full of experts who bring an array of drug research, design and development capabilities to our organization,” said Afeyan. “The strategic partnerships he has established signify not just a tremendous opportunity for patient impact and value creation, but represent a new, innovation supply chain model for collaborations within the broader biopharma ecosystem. Beyond this, Paul has provided instrumental leadership in various capacities across Flagship and has positively impacted our growth trajectory.”

Dina Ciarimboli has been appointed as General Counsel and Executive Partner to oversee legal, corporate, IP, compliance, and related matters for Flagship Pioneering and its ecosystem of internally-operated companies. She was most recently General Counsel at EQRx, and brings over 30 years of experience advising life sciences companies and venture capital funds on corporate strategy and operations spanning company creation, early research, clinical development, and commercial launch. Ciarimboli leads legal, corporate, IP, compliance, and related matters for Flagship Pioneering and its early stage, wholly owned companies. 

“We are pleased to have Dina Ciarimboli on board as our General Counsel,” added Afeyan. “Dina’s impressive track record includes over three decades of invaluable experience advising life sciences companies and venture capital funds, which makes her a great fit for this role. Dina’s expert guidance and counsel have quickly become an asset to Flagship and its wholly-owned companies.”

Marcello Damiani has been appointed Senior Partner with a responsibility for guiding and supporting Flagship and its ecosystem companies on digital, IT strategy and operations. Damiani joins Flagship from Moderna where he served as Chief Digital and Operational Excellence Officer, developing and leading a digitization strategy using cutting edge technologies such as robotics, automation cloud computing, and artificial intelligence/machine learning in support of Moderna’s transition from preclinical through to commercial therapeutics.

“Marcello executed a potent digitization strategy during his time at Moderna, using advanced technologies like robotics, automation, cloud computing, and artificial intelligence/machine learning, and his expertise makes him an invaluable addition to our team,” added Afeyan.

Gary Pisano, Ph.D., a long-time contributor to Flagship and for the last year an academic partner while on sabbatical from Harvard Business School, has joined Flagship full time as Executive Partner and Chief Strategist. Pisano most recently served as the Harry E. Figgie, Jr. Professor of Business Administration at the Harvard Business School, where he served as Senior Associate Dean for Promotions and Tenure and has taught MBA, executive, and doctoral courses. As Chief Strategist, Pisano is tasked with tackling the broad strategic and business model choices facing Flagship with a focus on operating effectively and efficiently at scale. Pisano will also be an important resource to Flagship companies on strategy and business model design.

“We have long valued Gary’s insight and strategy at Flagship, and we are pleased to welcome him as our Chief Strategist,” added Afeyan. “Gary’s counsel and singular understanding of the Flagship model will allow him to tackle the broad strategic and business choices facing Flagship with a focus on operating effectively and efficiently at scale. A key part of his role will be helping us leverage the company’s nearly 25 years of experience, and ensuring that Flagship operates on the leading edge of management, strategy, and leadership practice.”

Enhancing Flagship’s Leadership Team

Flagship further enhanced its leadership team with the following executive appointments and elevations:

Junaid Bajwa, M.D., will join Flagship in early September as Senior Partner and Head of United Kingdom, and Science Partner for Pioneering Intelligence. He will focus on advancing new strategic opportunities and partnerships in the region for Flagship and its companies. Bajwa will join Flagship from Microsoft Research where he has been serving as Chief Medical Scientist focusing on how trusted, reliable, and human-centered AI can transform the practice of medicine. He will bring over two decades of experience across primary care, secondary care, and public health settings, and has worked as a payer and policymaker in the UK, specializing in informatics, digital transformation, and leadership.David Khougazian was recently promoted to Executive Partner, Growth and Head of Global Engagement. David brings more than 25 years of leadership experience in the global healthcare industry including over two decades at Sanofi.Justine Levin-Allerhand, Ph.D., was recently promoted to Executive Partner, Origination and Corporate Development to maximize the effectiveness of Flagship’s origination teams, thereby fueling its ecosystem with exceptional company generation and novel, durable scientific platforms.Mark Stevenson joined Flagship as Senior Partner. In this role, he will help advance Flagship’s new Enabling Technologies Initiative (ETI) and focus on driving our external partnerships. Mark brings over 30 years in the life science industry to this role, including as Executive Vice President and Chief Operating Officer of Thermo Fisher.Flagship has also expanded its rank of origination partners through the promotions of Kyle Chiang, Molly Gibson, Scott Lipnick, Armen Mkrtchyan, and Jacob Rubens.

“Flagship is dedicated to hiring and nurturing world-class executives with a history of extraordinary performance, and with these additions to our already robust leadership team, I believe we are in the strongest place we’ve been in our nearly 25-year history,” added Afeyan. “We are pleased to congratulate our colleagues on their new and expanded leadership roles. We look forward to their collaboration as we build on our mission to invent transformative technologies and companies that improve human health and the sustainability of our planet.”

About Flagship Pioneering

Flagship Pioneering invents and builds bioplatform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $75 billion in aggregate value. To date, Flagship has deployed over $3.8 billion in capital toward the founding and growth of its pioneering companies alongside more than $27 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 40 companies, including Foghorn Therapeutics (NASDAQ: FHTX), Moderna (NASDAQ: MRNA), Sana Biotechnology (NASDAQ: SANA), Generate BiomedicinesInariIndigo Agriculture,  and Tessera Therapeutics.

Media Contact 

View original content to download multimedia:

SOURCE Flagship Pioneering

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


tKash Celebrates 1st Anniversary with Major Milestones and Exciting Promotions




Achieving 100,000 Registrations, International Reach, and Celebratory Promotions Highlight tKash’s Remarkable First Year

KUALA LUMPUR, Malaysia, July 19, 2024 /PRNewswire/ — tKash, a pioneering financial services app, is celebrating its first anniversary with notable achievements and exciting promotions. Launched with a vision to simplify financial transactions, tKash has reached impressive milestones, including 100,000 registrations and up to 10,000 daily active users.

Since its inception, tKash has been dedicated to providing seamless and secure financial services. The app has enabled users to transfer up to RM 1 million across borders, offering peace of mind with its reliable and efficient service. In addition to money transfers, tKash provides convenient currency exchange services for up to 10 countries’ currencies, including Bangladesh, Indonesia, India, the Philippines, Pakistan, Singapore, Vietnam, Thailand, and Myanmar.

One of the standout features of tKash is its Live FC (foreign currency) Rates, which allows users to track currency fluctuations in real time, ensuring they make informed decisions when exchanging currencies.

The company’s growth and success have not gone unnoticed. tKash proudly featured its video on the iconic New York Times Square billboard and displayed billboards in Kuala Lumpur, enhancing its brand visibility on an international scale. Influencers from countries such as Thailand have shared positive reviews on social media, further boosting tKash’s presence on social media.

To celebrate its first anniversary, tKash is running a special promotion where users who refer their friends have the chance to share in a RM100,000 prize pool, making it even more rewarding to engage with the app. The company continues to innovate, with regular updates to its app, which are available for download on both the PlayStore and AppStore. In January 2024, tKash launched its official website, providing users another platform to access its services.

In just one year, tKash has proven to be a game-changer in the financial services industry, making everyday transactions smoother and more accessible. With its tech-savvy team and commitment to customer satisfaction, tKash is poised for continued growth and success.

tKash is a leading financial services app committed to making financial transactions easier and more accessible. With secure money transfers, real-time currency exchange rates, and a user-friendly interface, tKash transforms how people manage their finances. For more information, visit

View original content to download multimedia:


Continue Reading


Saronic Raises $175 Million in Series B Funding, Valuing Company at $1 Billion




Funding will accelerate Saronic’s growth and further scale production of its autonomous surface vessels for the U.S. Navy and its allies

AUSTIN, Texas, July 19, 2024 /PRNewswire/ — Saronic, a defense technology leader that designs and manufactures autonomous surface vessels (ASVs), today announced a $175 million Series B raise placing the company’s valuation at $1 billion. The funding round was led by Andreessen Horowitz (a16z), with participation from both new and existing investors, including 8VC, Caffeinated Capital, Elad Gil, and NightDragon, among others.

Saronic is redefining maritime superiority for the U.S. Navy and its allies by delivering the most effective and advanced ASVs at the speed and scale needed to meet the rapidly growing needs of the Joint Force. Saronic’s ASVs are designed to serve as a force multiplier for the existing Fleet, working alongside manned systems to allow naval forces to go farther and do more with less risk to life and mission. 

“We are creating an entirely new capability for the maritime domain, one that delivers naval power without the costs and delays of a shipyard,” said Saronic CEO Dino Mavrookas. “As the future of naval warfare will rely on manned and unmanned teaming, we must build solutions that easily integrate into the existing fleet and can be produced at scale to meet any emerging threat. We are grateful to our investment partners who believe so strongly in Saronic’s ability to meet that need.”

Saronic’s investor group is composed of firms committed to ensuring that the U.S. military maintains its decisive advantage in the face of an increasingly complex and competitive global threat landscape through the integration of advanced technology and innovative capabilities that truly meet the needs of the warfighter. 

“Our nation’s future depends on us continuing to build and deploy the best, most innovative technology” said Katherine Boyle, General Partner at a16z. “Saronic is developing the solutions we need to protect the warfighter and stay ahead of our adversaries, and we are proud to support their continued growth.”

This new investment will accelerate Saronic’s growth both domestically and internationally. At home, it will allow further expansion of Saronic’s in-house manufacturing capabilities and enable increased production of all its ASV models. Additionally, it will advance the research and development of new autonomous capabilities for naval and maritime forces, including increased technology and payload integration with government and commercial partners. Internationally, this investment will support Saronic’s expansion to more fully serve U.S. allies and partners in key markets.

“To deter China and other adversaries, the United States and our allies must bring intelligent, autonomous new capabilities to naval warfare,” said Alex Moore, Partner at 8VC. “Saronic delivers these capabilities on a relevant scale and timeline, and has enlisted the top engineers and operators in the industry.”

Saronic’s family of ASVs includes Spyglass (6′), Cutlass (14′) and Corsair, its largest model, which is currently in development and testing. Each vessel features integrated autonomous capabilities to meet a customer’s specific requirements and can carry diverse payloads in communication- and GPS-denied environments. Through the vertical integration of hardware and software as well as the use of a Modular Open Systems Architecture (MOSA), Saronic’s ASVs deliver greater interoperability at a price point that makes them attritable. Having a cost-effective capability that can be deployed without putting human operators in harm’s way increases the survivability of the fleet and enables commanders to engage in situations where the risk is too high to deploy a traditional manned system.

For more information about Saronic, please visit:  

Media Contact: 


View original content to download multimedia:

SOURCE Saronic

Continue Reading


Summit-Friendship Solar Village Receives Reuters’ Global Energy Transition Awards 2024




SINGAPORE, July 19, 2024 /PRNewswire/ — The ‘Summit-Friendship Solar Village’ project, located in Kabilpur within the Gaibandha district of Bangladesh, has received the prestigious Reuters’ Global Energy Transition Awards 2024 under the ‘Projects of Impact’ category in New York, USA on 25th June 2024. Among 500 entries this year from around the globe, this project was nominated for its concrete results in terms of improved energy affordability, and compensation for losses to improve local resilience for climate change.

This 57.6 kW scalable solar microgrid now benefits the 3,000 inhabitants of Kabilpur, Gaibandha. Kabilpur itself is a char—a remote sedimentary landmass found within a river—but finds itself ideally placed to act as hub for neighbouring chars within the Jamuna River, upon which it is situated.

“Summit wants to serve 100% of Bangladesh with infrastructure such as electricity and communication. Most chars fall outside the national grid. I believe these chars, like the rest of Bangladesh, deserve electricity. The award-winning NGO, Friendship, has done wonders. It’s a privilege to provide solar energy to the 3,000 people of Kabilpur Char in association with Friendship,” remarked Muhammed Aziz Khan, Chairman of Summit Power International.

“Anyone who has seen the Jamuna River in its full might will understand that mainline power grids are not really possible here. On the other hand, this solar grid will provide income-generating opportunities and livelihoods, as well as opportunities for children’s education in order for hope and dignity to thrive. We want to thank Summit for its support,” said Runa Khan, the founder of Friendship.

The solar village plays an integral role in allowing people from these isolated communities to have access to “modern” amenities, and have longer operational hours for both business and commerce, alongside academics and home use. Additionally, renewable solar energy also equates to less reliance on traditional kerosene lamps, which burn fossil fuels with toxic consequences.

About Summit Power International 

Summit Group is the largest infrastructure conglomerate in Bangladesh. Summit Power International Ltd (SPI), headquartered in Singapore, is the largest Independent Power Producer (IPP) in Bangladesh reflecting 17% of Bangladesh’s total private installed capacity and 7% of nation’s total installed capacity. In addition, it owns and operates a Floating Storage and Regasification Unit (FSRU) vessel and supplies 500 million cubic feet per day (mmcfd) of regasified LNG to Bangladesh. In 2019, Summit’s FSRU received equity investment from Mitsubishi Corporation. In 2019, JERA Co., Inc. (JERA), had acquired a 22% stake in Summit Power International. Recently, it has proposed the development of the country’s third FSRU and the Cabinet Committee on Economic Affairs has provided in-principle approval of the proposal in mid-June 2023. Most notably, the Meghnaghat II, which is a dual-fuel CCGT GE H Class plant with gross capacity of 590 MW on LNG, achieved the commercial operation date milestone on 26 April 2024.

View original content to download multimedia:

SOURCE Summit Power International

Continue Reading